Multiplex

Newly Engineered Versions of Bacterial Enzyme Reveal How Antibiotics Could Be More Potent

Retrieved on: 
Wednesday, August 30, 2023

NEW YORK, Aug. 30, 2023 /PRNewswire/ -- Modern medicine depends on antibiotics to treat infections by disabling targets inside bacterial cells.

Key Points: 
  • NEW YORK, Aug. 30, 2023 /PRNewswire/ -- Modern medicine depends on antibiotics to treat infections by disabling targets inside bacterial cells.
  • Once inside these cells, antibiotics bind to certain sites on specific enzyme targets to stop bacterial growth.
  • Researchers have for decades studied resistant mutants in hopes that related mechanisms would guide the design of new treatments to overcome resistance.
  • Not only does the antibiotic prevent these mutants from growing, it nearly obliterates the mutant bacterial populations.

Respiratory Infection Diagnostic Market Research Report 2023 - Technologies Compete for the Diagnostic Gold Rush - ResearchAndMarkets.com

Retrieved on: 
Monday, January 30, 2023

The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
  • COVID-19 has broken open the market for point of care testing of respiratory infections.
  • And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well.
  • The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous.

Global Respiratory Infection Diagnostic Market Analysis Report 2023: Explore the Rapidly Changing Market as Competitors Jockey for Position in New Markets

Retrieved on: 
Tuesday, January 31, 2023

COVID-19 has broken open the market for point of care testing of respiratory infections.

Key Points: 
  • COVID-19 has broken open the market for point of care testing of respiratory infections.
  • And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well.
  • Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood.
  • The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous.

GREAT GULF GROUP APPOINTS NEIL VOHRAH PRESIDENT HIGH-RISE RESIDENTIAL NORTH AMERICA

Retrieved on: 
Wednesday, January 25, 2023

TORONTO, Jan. 25, 2023 /PRNewswire/ - Bill Tresham, Executive Chairman Great Gulf Group is pleased to announce the appointment of Neil Vohrah as President High-Rise Residential North America.

Key Points: 
  • TORONTO, Jan. 25, 2023 /PRNewswire/ - Bill Tresham, Executive Chairman Great Gulf Group is pleased to announce the appointment of Neil Vohrah as President High-Rise Residential North America.
  • He joins Business Leads: Katy Schofield, Low Rise Canada; David Carreiro, First Gulf; Chris Mallinos, Tucker HiRise; Tad Putyra, H+ME Technology; Michael Sneyd, Resort Residential; and Kiel O'Sullivan, Granden Living at Great Gulf Group.
  • "We are delighted to have Neil join Great Gulf Group to lead the expansion of the high-rise residential platform in North America," said Bill Tresham, Executive Chairman Great Gulf Group.
  • Neil holds a Bachelor of Science (Honours) and a postgraduate Bachelor of Architecture degree from Cardiff University, UK.

Hudson Opens New Retail And Food & Beverage Experience At Dallas Fort Worth Int’l Airport

Retrieved on: 
Thursday, October 6, 2022

From the food to the overall experience, our new Decanted and Hudson Nonstop concept allows travelers to shop and eat the way they want to, said Evan Schut, SVP of Food & Beverage of Hudson.

Key Points: 
  • From the food to the overall experience, our new Decanted and Hudson Nonstop concept allows travelers to shop and eat the way they want to, said Evan Schut, SVP of Food & Beverage of Hudson.
  • Our team members care for travelers as friends at our travel convenience, specialty retail, duty free and food and beverage destinations.
  • Dallas Fort Worth International (DFW) Airport is the most connected airport in the world.
  • Centered between owner cities Dallas and Fort Worth, Texas, DFW Airport also serves as a major job generator for the North Texas region by connecting people through business and leisure travel.

Hudson Opens New Retail And Food & Beverage Experience At Dallas Fort Worth Int’l Airport

Retrieved on: 
Thursday, October 6, 2022

From the food to the overall experience, our new Decanted and Hudson Nonstop concept allows travelers to shop and eat the way they want to, said Evan Schut, SVP of Food & Beverage of Hudson.

Key Points: 
  • From the food to the overall experience, our new Decanted and Hudson Nonstop concept allows travelers to shop and eat the way they want to, said Evan Schut, SVP of Food & Beverage of Hudson.
  • Our team members care for travelers as friends at our travel convenience, specialty retail, duty free and food and beverage destinations.
  • Dallas Fort Worth International (DFW) Airport is the most connected airport in the world.
  • Centered between owner cities Dallas and Fort Worth, Texas, DFW Airport also serves as a major job generator for the North Texas region by connecting people through business and leisure travel.

Disperse Raises $16 Million in Funding Led by 2150

Retrieved on: 
Tuesday, September 27, 2022

Disperse, a leading provider of building productivity systems in the construction industry, has raised $16 million of additional funding, with 2150 as lead investor and participation from existing investors including Northzone and Kindred Capital.

Key Points: 
  • Disperse, a leading provider of building productivity systems in the construction industry, has raised $16 million of additional funding, with 2150 as lead investor and participation from existing investors including Northzone and Kindred Capital.
  • Using Disperse systems, project teams are freed from repetitive administrative tasks and protected against unchecked construction errors and costly rework.
  • Disperse was founded in 2015 out of a London School of Economics entrepreneurship incubator.
  • 2150 is the ideal partner, and we are proud to have their backing, said Felix Neufeld, CEO and founder of Disperse.

Holiday Rambler® Brand of Motorhomes Debuts Impressive New Model

Retrieved on: 
Tuesday, August 30, 2022

The luxury Eclipse model is available in three different floorplans and three different lengths to meet a variety of owner preferences.

Key Points: 
  • The luxury Eclipse model is available in three different floorplans and three different lengths to meet a variety of owner preferences.
  • View the full release here: https://www.businesswire.com/news/home/20220830005646/en/
    Designed to stand out, the Eclipse is a brand new Class A Gas motorhome from Holiday Rambler that has a bevy of sought-after features RVers are sure to appreciate.
  • The luxury Eclipse model is available in three different floorplans and three different lengths to meet a variety of owner preferences.
  • Holiday Rambler is a brand within REV Recreation Group, Inc., a subsidiary of REV Group, Inc.
    To see the latest Holiday Rambler models and for travel tips and ideas, visit HolidayRambler.com or follow Holiday Rambler on Facebook and Instagram .

Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

Retrieved on: 
Thursday, May 26, 2022

MINNEAPOLIS, May 26, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary milestone of developing over 40,000 unique RNAscope in situ Hybridization (ISH) probes in over 400 species. ACD's broad portfolio of RNAscope probes enables ground-breaking scientific discoveries, accelerates the development of next generation therapeutics, and delivers critical diagnostic applications.

Key Points: 
  • MINNEAPOLIS, May 26, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary milestone of developing over 40,000 unique RNAscope in situ Hybridization (ISH) probes in over 400 species.
  • ACD's broad portfolio of RNAscope probes enables ground-breaking scientific discoveries, accelerates the development of next generation therapeutics, and delivers critical diagnostic applications.
  • Bio-Techne's ACD has been pioneering the spatial biology market for over 10 years with patented RNAscope ISH Technology, enabling RNA tissue imaging at single-molecule sensitivity and single-cell resolution, while retaining the tissue morphological context.
  • The RNAscope Technology portfolio, including HiPlex, Multiplex, BaseScope, DNAscope and the Integrated Co-Detection Workflow (ICW) for proteins, can be readily performed in most laboratories.

Lunaphore and Visiopharm Announce New Partnership to Offer Spatial Biology Research Solution With Deep Learning Technology

Retrieved on: 
Wednesday, May 4, 2022

Under the partnership, the companies will co-market a complete end-to-end solution that offers hyperplex immunofluorescence staining, image acquisition, and subsequent analysis with deep learning.

Key Points: 
  • Under the partnership, the companies will co-market a complete end-to-end solution that offers hyperplex immunofluorescence staining, image acquisition, and subsequent analysis with deep learning.
  • COMET and Oncotopix Discovery are compatible natively, and the combined offering provides an all-encompassing, interoperable spatial biology and data analysis solution for researchers.
  • With the launch of Oncotopix Discovery, the most robust version of their respected research image analysis software platform to date, Visiopharm brings the power of deep learning to all.
  • By combining our leading spatial biology platform with Visiopharms deep learning capabilities, this collaboration can make it easier for laboratories to adopt and integrate spatial biology solutions for their research.